According to a study by Zuo et al. [13], vitamin D-activated long non-coding RNA MEG3 reduces glycolysis in CRC via encouraging c-Myc degradation, pointing to vitamin D as a possible treatment target. Here, MYC is linked to colorectal carcinoma.